Literature DB >> 6517552

Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.

M B Bansal, S K Chuah, H Thadepalli.   

Abstract

Azlocillin was active against 90% of 154 strains of Bacteroides fragilis at a concentration of 64 micrograms/ml. Twenty-eight strains of B. fragilis with an azlocillin MIC of greater than or equal to 8 micrograms/ml were retested with a combination of azlocillin plus clavulanic acid. Of these strains, 71% showed a 4- to 32-fold decrease in the MIC of azlocillin plus clavulanic acid.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6517552      PMCID： PMC179977          DOI： 10.1128/AAC.26.4.606

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.

Authors:  R Wise; A P Gillett; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

2.  [Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria].

Authors:  H B König; K G Metzger; R P Mürmann; H A Offe; P Schacht; W Schröck
Journal:  Infection       Date:  1977       Impact factor: 3.553

3.  Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure.

Authors:  A Arank; S A Syed; E B Kenney; R Freter
Journal:  Appl Microbiol       Date:  1969-04

4.  Clavulanic acid and susceptibility of Bacteroides fragilis to penicillin.

Authors:  R Wise
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

5.  Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.

Authors:  M A Crosby; D W Gump
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.

Authors:  R Wise; A P Gillett; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

7.  Azlocillin and mezlocillin: new ureido penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.

Authors:  I Roy; V Bach; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

9.  Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.

Authors:  R Martinelli; A A Lopes; M M de Oliveira; H Rocha
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191
  9 in total
  3 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers.

Authors:  G W Welling; G Groen; S Welling-Wester; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

Review 3.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.